Medline Inc（MDLN）财务数据MDLNMedline Inc

Medline Inc. (MDLN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Supply Chain Solutions, accounting for 53.9% of total sales, equivalent to $4.14B. Other significant revenue streams include Medline Brand - Front Line Care and Medline Brand - Surgical Solutions. Understanding this composition is critical for investors evaluating how MDLN navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Medline Inc. maintains a gross margin of 26.52%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 9.89%, while the net margin is 1.81%. These profitability ratios, combined with a Return on Equity (ROE) of 4.92%, provide a clear picture of how effectively MDLN converts its operational activities into shareholder value.

In the context of the broader market, MDLN competes directly with industry leaders such as IDXX and A. With a market capitalization of $46.99B, it holds a leading position in the sector. When comparing efficiency, MDLN's gross margin of 26.52% stands against IDXX's 64.04% and A's 55.48%. Such benchmarking helps identify whether Medline Inc. is trading at a premium or discount relative to its financial performance.

Medline's revenue has shown consistent growth, with Q2 2026 revenue at $7.7 billion, up 11.6% year-over-year. The gross margin improved to 26.52% in Q2 2026, indicating better profitability.